New Covid variants account for 70% of new infections in Switzerland swissinfo.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swissinfo.ch Daily Mail and Mail on Sunday newspapers.
Published: Feb 05, 2021 By Gail Dutton
Alexanderstock23 / Shutterstock
AstraZeneca’s rolling authorization application for its COVID-19 vaccine a few days ago, saying more data is needed “to obtain more information about safety, efficacy, and quality.”
AstraZeneca’s Phase III clinical trial of ChAdOx1 nCoV-19 (AZD1222) shows 76% efficacy after the initial dose and 82% efficacy 12 weeks later, after the second dose. Data show it actually increases efficacy by extending the time between doses. The vaccine already is approved by the E.U. and by approximately 40 countries, including the U.K.
None-the-less, Swissmedic concluded, “The data submitted and analyzed so far are not yet sufficient to permit authorization.”
Novartis agrees to help Pfizer-BioNTech produce Covid-19 vaccine
Novartis is based in Basel Keystone / Georgios Kefalas
Swiss pharma giant Novartis says it has signed an initial agreement to provide manufacturing capacity for Pfizer and BioNTech s Covid-19 vaccine.
This content was published on January 29, 2021 - 13:14
January 29, 2021 - 13:14
Reuters/Novartis/SWI swissinfo.ch/ilj
See in other languages: 3
The move aimed at helping boost production as demand currently outstrips supply. The agreement will see Novartis utilizing its aseptic manufacturing facilities at its site in Stein, Switzerland, Novartis said in a statement on Friday. External link Subject to reaching a final agreement, Novartis plans to commence production in the second quarter of 2021.
Swiss exempt from EU vaccine export controls
European Commissioner Valdis Dombrovskis speaks during an online news conference on Friday Copyright 2020 The Associated Press. All Rights Reserved
Switzerland is among the countries exempt from the European Union’s vaccine export controls, the European Commission said on Friday. The plan has been drawn up to ensure that the EU has enough supplies of Covid-19 vaccine.
This content was published on January 29, 2021 - 18:22
January 29, 2021 - 18:22
Reuters/Keystone-SDA/SWI swissinfo.ch/ilj
EU trade commissioner Valdis Dombrovskis told a news conference that the export monitoring and controls were time limited , initially lasting until the end of March, and applied to Covid-19 vaccines the EU had bought in advance.